Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
BIIB
#440
Biogen Inc. - Common Stock
221.5
0
USD
0.00%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.19%
Monthly Change
+5.06%
6 month change
+17.18%
Year Change
+67.17%
Previous Close
221.0
7
Open
221.5
0
Low
221.5
0
High
221.5
0
Volume
133
Markets
US Stock Market
Healthcare
Drug Manufacturers—General
BIIB
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
1997
Quarterly report, Q2 FY1997
1997.08.14
BIOGEN INC. quarterly report, Q2 FY1997
10-Q
Quarterly report, Q1 FY1997
1997.05.15
BIOGEN INC. quarterly report, Q1 FY1997
10-Q
1996
Quarterly report, Q3 FY1996
1996.11.13
BIOGEN INC. quarterly report, Q3 FY1996
10-Q
Quarterly report, Q2 FY1996
1996.08.14
BIOGEN INC. quarterly report, Q2 FY1996
10-Q
1
2
3
4
5
6
7
8
9
News
FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
TG Therapeutics: Briumvi's Peak May Be Far Away (Rating Upgrade) (NASDAQ:TGTX)
Acadia Pharmaceuticals: Another Bite At The Alzheimer's Apple (NASDAQ:ACAD)
TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors (NASDAQ:TGTX)
Making Drugs With AI: Biopharma Giants Gear Up For New Arena
Should You Buy, Sell or Hold Biogen Stock After a 9% Rise in a Month?
Is Wall Street Bullish or Bearish on Biogen Stock?
Can ABBV's Neuroscience Drugs Drive Growth in the Second Half of 2026?
DNLI Q2 Loss Narrows, Avlayah Sales Drive Strong Launch Momentum
Biogen Stock: How To Find & Own America's Greatest Opportunities
IONS Beats Q2 Earnings & Sales Estimates, Reiterates '26 Outlook
Drugmakers Climb On Q2 Reports, Even As One Misses Profit Views